This shift raises important questions about safety, tolerability, and long-term outcomes
Description About Sembolic 3 Semaglutide Tablets Sembolic 3 Semaglutide Tablets contain semaglutide 3 mg, an oral glucagon-like peptide-1 receptor agonist, often shortened to GLP-1 receptor agonist
However, they arent perfect
However, the compounded version of semaglutide is not FDA-approved, raising questions about its composition and safety
TRIUMPH-4: Efficacy at 68 weeks TRIUMPH-4 (ClinicalTrials.gov identifier NCT05931367) enrolled 445 adults with obesity or overweight plus symptomatic knee osteoarthritis and no type 2 diabetes
"If they're not providing you that offer of patient counseling or you're calling into that pharmacy and they don't allow you to, you know, be progressed to a pharmacist where you can ask questions, that would be something that I would call a red flag." She says prices that are too low and pharmacies that don't ask for a prescription should also trigger alarm bells